Tomoe Kanbara
Toyonaka, 5610825, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Characterization of CNS Network Changes in Two Rodent Models of Chronic Pain.
Journal: Biological & pharmaceutical bulletin
Published: September 10, 2025
Allosteric inhibition of phosphodiesterase 4D induces biphasic memory-enhancing effects associated with learning-activated signaling pathways.
Journal: Psychopharmacology
Published: September 05, 2023
The contribution of Gi/o protein to opioid antinociception in an oxaliplatin-induced neuropathy rat model.
Journal: Journal of pharmacological sciences
Published: October 28, 2014
Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.
Journal: Journal of pharmacological sciences
Published: August 22, 2014
Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
Journal: Journal of pharmacological sciences
Published: June 27, 2014
Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model.
Journal: British journal of pharmacology
Published: May 01, 2014
Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model.
Journal: Neuroscience letters
Published: April 23, 2014
G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
Journal: British journal of pharmacology
Published: July 12, 2013
Differential activation of the μ-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model.
Journal: British journal of pharmacology
Published: February 07, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026